|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-5-10
|
|
pubmed:abstractText |
Venom immunotherapy (VIT) enables longtime prevention of insect venom allergy in the majority of patients. However, in some, the risk of a resystemic reaction increases after completion of treatment. No reliable factors predicting individual lack of efficacy of VIT are currently available.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1097-6825
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
125
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1092-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20334904-Adult,
pubmed-meshheading:20334904-Aged,
pubmed-meshheading:20334904-Animals,
pubmed-meshheading:20334904-Arthropod Venoms,
pubmed-meshheading:20334904-Bee Venoms,
pubmed-meshheading:20334904-Bees,
pubmed-meshheading:20334904-Desensitization, Immunologic,
pubmed-meshheading:20334904-Female,
pubmed-meshheading:20334904-Gene Expression Profiling,
pubmed-meshheading:20334904-Humans,
pubmed-meshheading:20334904-Hypersensitivity, Immediate,
pubmed-meshheading:20334904-Immunotherapy,
pubmed-meshheading:20334904-Insect Bites and Stings,
pubmed-meshheading:20334904-Male,
pubmed-meshheading:20334904-Middle Aged,
pubmed-meshheading:20334904-Treatment Outcome,
pubmed-meshheading:20334904-Wasp Venoms,
pubmed-meshheading:20334904-Wasps
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.
|
|
pubmed:affiliation |
Department of Allergology, Medical University of Gdansk, Debinki 7 80-952 Gdansk, Poland. mnied@amg.gda.pl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
